Merck says its HPV vaccine for men was approved by China's drug regulator
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's medical products administration.
Merck (MRK) Rises Higher Than Market: Key Facts
Merck (MRK) closed at $99.72 in the latest trading session, marking a +0.59% move from the prior day.
UK approves Merck's therapy for rare lung condition
UK's Medicines and Healthcare products Regulatory Agency (MHRA) said on Tuesday it had approved Merck's therapy to treat a rare lung condition called pulmonary arterial hypertension.
Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Merck (MRK) closed the most recent trading day at $99.45, moving +0.08% from the previous trading session.
Is Merck the Next Big Weight-Loss Stock?
Watch out, Eli Lilly and Novo Nordisk. Merck (MRK -1.48%) is hungrily looking to take a bite out of the weight-loss drugs market.
MRK's Pivotal Study on Two-Drug, Once-Daily HIV Pill Meets Goals
Merck posts positive data from two phase III studies evaluating a two-drug, single-tablet regimen of doravirine/islatravir in adults with HIV-1 infection.
Merck's weight-loss pill deal: what it means for Eli Lilly
Merck & Co Inc (NYSE: MRK) is in focus this morning after announcing a $2.0 billion deal with Hansoh Pharma. The said agreement wins it rights to HS-10535 – an experimental weight-loss pill (oral)...
Merck discontinues development of 2 cancer drugs after trial failures
Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.
Merck Has Become Very Cheap Again
Merck's shares have declined, making its dividend yield climb and valuation compress, presenting an attractive investment opportunity at current prices. Keytruda, the company's largest drug, contin...
Merck (MRK) Ascends While Market Falls: Some Facts to Note
Merck (MRK) reachead $101.25 at the closing of the latest trading day, reflecting a +1.5% change compared to its last close.
Merck (MRK) Stock Sinks As Market Gains: Here's Why
Merck (MRK) closed at $99.75 in the latest trading session, marking a -1.24% move from the prior day.
Merck & Co., Inc. (MRK) 7th Annual Evercore ISI HealthCONx Conference (Transcript)
Merck & Co., Inc. (NYSE:MRK ) 7th Annual Evercore ISI HealthCONx Conference December 3, 2024 1:20 PM ET Company Participants Peter Dannenbaum - SVP, IR Eliav Barr - Chief Medical Officer Conference...
Why Is Merck Stock Trading Higher On Monday?
On Monday, Merck & Co Inc MRK revealed topline results from the Phase 3 ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary arterial hypertension (PAH, WHO Group 1) functi...
Merck's WELIREG® (belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associate...
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck's WELIREG Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors.
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
Related Companies